SCHEMBL8091693

SCHEMBL8091693

Cn1cc(NC(=O)Nc2ccc(-c3nc(N)cc(C4(S(C)(=O)=O)CCC4)n3)cc2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.40
KDR P35968 7/20 0.37
FGFR1 P11362 5/20 0.37
EGFR P00533 3/20 0.37
PIK3CD O00329 2/20 0.36
PIK3CA P42336 1/20 0.36
MAOA P21397 1/20 0.36
AURKB Q96GD4 5/20 0.36
MAPK1 P28482 1/20 0.36
NTRK1 P04629 5/20 0.36
RET P07949 4/20 0.36
EPHB2 P29323 2/20 0.36
EPHX2 P34913 1/20 0.36
MAP4K1 Q92918 2/20 0.36
DHX9 Q08211 1/20 0.36
ATR Q13535 2/20 0.36
PLK4 O00444 3/20 0.35
AURKA O14965 3/20 0.35
MAP4K4 O95819 3/20 0.35
ABL1 P00519 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083835 0.92 MTOR (0.39) MTORKDRFGFR1EGFRPIK3CD
SCHEMBL8096057 0.92 MTOR (0.43) MTORPIK3CDPIK3CAATR
SCHEMBL8097088 0.86 TSHR (0.47) PIK3CDPIK3CAAURKBMAPK1
SCHEMBL8097556 0.86 PIK3CA (0.42) MTORPIK3CDPIK3CAATR
SCHEMBL8097252 0.84 CA12 (0.43) MTORPIK3CDPIK3CAEPHX2ATR
SCHEMBL8098293 0.84 PIK3CA (0.42) MTORPIK3CDPIK3CAATR
SCHEMBL8103635 0.83 ATR (0.39) MTORPIK3CDPIK3CAATR
SCHEMBL8089909 0.83 MTOR (0.45) MTORPIK3CDPIK3CADYRK1A
SCHEMBL8091635 0.83 ATR (0.47) MTORKDRFGFR1PIK3CDPIK3CA
SCHEMBL8098306 0.82 CA12 (0.42) MTORKDRPIK3CDPIK3CAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed